# FDA Inspection 1099767 - Octapharma Plasma Inc - July 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/625eb533-e694-46fd-9326-cfbd1823cf89
Source feed: FDA_Inspections

> FDA Inspection 1099767 for Octapharma Plasma Inc on July 24, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099767
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2019-07-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 897084 - 2014-09-17](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/375d50ca-4da7-49cb-ac5d-51d2c2c13b00)
- [FDA Inspection 800541 - 2012-09-13](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a458564a-20f8-4479-9196-f3ea02bdc456)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/6f30fca9-f49b-4d6a-b3c3-5fb3d050fb3f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d